Deep Vein Thrombosis
The Clinical Practice Guidance document issued by the EHA, ISTH, EAHAD, and ESO addresses both hemophilia A and B.
In findings arterial thrombosis carried worse overall survival than venous thrombosis in this patient population.
The new agent is on the 505(b)(2) regulatory pathway and was compared with tablet-form apixaban in 60 healthy volunteers.
Patients with RA had a 57% increased risk of VTE; a 58% increased risk of DVT; and a 57% increased risk of PE.
Thrombectomy treatment of iliofemoral DVT reduced the incidence of post-thrombotic syndrome compared with anticoagulants.
Tranexamic acid did not seem to increase risk of postoperative complications in patients undergoing total joint arthroplasty.
Asymptomatic DVT incidence was similar in patients with benign and malignant diseases prior to surgery for benign disease.
Edoxaban therapy for 12 months was superior to three-month therapy for preventing venous thromboembolisms and related deaths.
Research has found that NSAID use was positively associated with the development of VTE in women of reproductive age.
According to a study, apixaban was associated with a lower bleeding risk for patients with first-time venous thromboembolism.
Advertisement
Expert Interviews on Hematology
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.